Accretion Nutraveda
Open Date
28 Jan 2026
Close Date
30 Jan 2026
Min Investment
₹258000
Lot Size
2000 Shares
Issue Size
₹24.77 Cr
Price Range
₹122 - ₹129
Listing Date
Feb 4, 2026
IPO Doc
RHP PDFAbout Accretion Nutraveda
Incorporated in the year 2021, Accretion Nutraveda is engaged in the manfacturing of Ayurvedic and nutraceutical products in different dosage forms, which include tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.The company is a Contract Development and Manufacturing Organization (CDMO) that caters to both local and international markets, including Sri Lanka, Singapore, and USA. It provides products that incorporate the wisdom of Ayurvedic science, along with the latest nutraceutical technology, to alleviate conditions such as liver care, women’s health, boneness and joint care, brain support, and respiratory health.Business verticals:Domestic Sales & Merchant Exports (Loan Licence Basis) - contributing 96.62% to total revenues in FY 2024-25.Direct Exports– Contributing 38%, with a constant rise in It has a manufacturing plant in Gujarat which occupies around 10,763 sq. ft. and is well-equipped with latest infrastructure like 13 air handling units, processing areas, and quality control equipment. The plant is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified along with FSSAI license.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Accretion Nutraveda IPO - Issue Objectives
The company will spend ₹4.21 cr on automation machinery for its current plant. The company will fund ₹8.03 crore to purchase machinery for the new manufacturing setup. The company will use ₹5.50 crore for its working capital requirement. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Capex for existing plant
16.88%
Capex for new unit
32.12%
Working capital requirement
22%
General corporate purposes
29%
Capex for existing plant
The company will spend ₹4.21 cr on automation machinery for its current plant.
Capex for new unit
The company will fund ₹8.03 crore to purchase machinery for the new manufacturing setup.
Working capital requirement
The company will use ₹5.50 crore for its working capital requirement.
General corporate purposes
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
IPO Subscription Status
Financials of Accretion Nutraveda
In Cr.
Revenue: ₹16.06
EBITDA: ₹3.65
Profit: ₹2.61
| Key Performance Indicator | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) | 31-Mar-23 (In Cr.) |
|---|---|---|---|
| Revenue | 16.06 | 5.20 | 3.07 |
| EBITDA | 3.65 | 1.21 | 0.59 |
| Expenses | |||
| Profit After Tax | 2.61 | 0.82 | 0.28 |
| Assets | 10.86 | 4.64 | 4.06 |
| Net Worth | 5.35 | 1.08 | 0.26 |
| Reserves | 4.86 | 0.72 | -0.10 |
| Borrowing | 3.86 | 2.17 | 1.97 |
Contact Details
Accretion Nutraveda
27 Xcelon Industrial Park-1 Vasna-Chacharwadi, Ta-Sanand, Ahmedabad, Gujarat, 382213
Registrar Contact Details
Accretion Nutraveda IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 157.00 | |
 Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |
